Edwards Lifesciences Stock: High Growth Rates Are Already Priced In (NYSE:EW)
seekingalpha.com
finance
2022-06-05 11:32:03

SomkiatFakmee/iStock via Getty Images The last few months certainly weren't easy for investors and clearly demonstrated that companies with extremely high valuation multiples face a high risk of declining steeply. Of course, we already knew this before but from time-to-time investors seem to forget these lessons and suddenly we have stocks with triple digit price-earnings or price-free-cash-flow ratios that are considered as cheap and undervalued. But these high-flyers, which are priced for perfection, will also return to reasonable valuation levels at some point.
